A drug used to treat psoriasis may also be able to help treat people with type 1 diabetes, BBC News reported.
In a study published in The Lancet Diabetes and Endocrinology, 33 patients with type 1 diabetes received weekly injections of the psoriasis drug alefacept for 12 weeks, followed by a 12-week break in treatment. After the hiatus, the patients then underwent another 12 weeks of injections. A second group of patients received placebo injections over the same period of time.
Hey, check out all the research scientist jobs. Post your resume today!
